SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902664-24-002242
Filing Date
2024-03-06
Accepted
2024-03-06 19:30:09
Documents
3
Group Members
CALIGAN PARTNERS LPDAVID JOHNSONWILLIAM JELLISON

Document Format Files

Seq Description Document Type Size
1 ANIKA THERAPEUTICS, INC. p24-1111sc13da.htm SC 13D/A 95040
2 JOINT FILING AGREEMENT p24-1111exhibit99_2.htm EX-99 4678
3 FORM OF NOMINEE AGREEMENT p24-1111exhibit99_3.htm EX-99.3 19065
  Complete submission text file 0000902664-24-002242.txt   120659
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Subject) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45573 | Film No.: 24727727
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 515 MADISON AVENUE 8TH FLOOR NEW YORK NY 10022
Business Address 515 MADISON AVENUE 8TH FLOOR NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A